GIPERPROLAKTINEMIYA SINDROMI

Authors

  • Hasanov A’zamxon Respublika ixtisoslashtirilgan Endokrinogiya ilmiy amaliy tibbiyot muasasasi Klinik ordinator Author

Keywords:

Giperprolaktinemiya, prolaktin, prolaktinoma, endokrinologiya, amenoreya, galaktoreya, diagnostika, davolash, reproduktiv tizim.

Abstract

Ushbu mavzuda giperprolaktinemiya sindromining patogenezi, klinik ko‘rinishlari, diagnostikasi va davolash usullari ko‘rib chiqilgan. Giperprolaktinemiya — prolaktin gormoni darajasining qon plazmasida oshishi bilan tavsiflanadigan endokrin buzilish bo‘lib, reproduktiv tizimga va umumiy sog‘liqqa ta’sir ko‘rsatadi. Maqolada sindromning turli sabablaridan, jumladan, fiziologik, farmakologik va patologik omillardan kelib chiqishi, shuningdek, prolaktinoma kabi asosiy etiologik omillar batafsil tahlil qilingan. Zamonaviy diagnostika usullari va terapevtik yondashuvlar ham taqdim etilgan.

Downloads

Download data is not yet available.

References

Nazarov Sh.A. Endokrin kasalliklar. Ilm-Ziyo, Toshkent.2018. 75–90 betlar.

To‘xtayev A.X.Ayollarda gormonal buzilishlar. Samarqand: Sog‘liq, 2020.

–68 betlar.

Raximova D.M., Islomova N.I. Endokrinologiyaning asosiy savollari

Toshkent: Fan, 2019. 112–125. betlar.

Karimov B.T. Gormon kasalliklari diagnostikasi va terapiyasi

Innovatsiya Ziyo, Buxoro. 2021. 88–101 betlar.

Xolmurodova S.F. Ayollar sog‘lig‘i va endokrinologiya. Yangi Avlod, Namangan. 2022. 40–53 betlar.

Almuradova, D. M., Mukumova, D. I., & Turaeva, X. K. (2022). Karlibaev AO Modern endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer. Образования и наука в ХХI веке, 24(2), 773-780.

Juraev, M. D., Atakhanova, N. E., Almuradova, D. M., & Gaziev, L. T. (2023). Androgen receptor values for prediction of survival of patients with three times negative breast cancer. EPRA International Journal of Research and Development (IJRD), 8(6), 104-106.

Tursunova, N. I., Almuradova, D. M., Turayeva Kh, K. H., & Muqimova, D. I. (2022). Hereditary breast and ovarian cancer. EDUCATION AND SCIENCE IN THE XXI CENTURY, (24), 1200-1212.

Атаханова, Н. Э., & Алмурадова, Д. М. (2022). Влияние экспрессии андрогеновых рецепторов на прогноз трижды негативного рака молочной железы. Клиническая и экспериментальная онкология, 10(2), 112-115.

Almuradova, D. M., Sh, O. S., & Ubaydullaev, I. A. (2021). Sharobiddinov BB Islamov SB A Modern Approach to Diagnosis and Treatment of Breast Cancer Releases. Central Asian Journal of Medical and Natural Science, 2(5), 294-298.

Tilyashaikhov, M. N., Gaziev, L. T., Almuradov, A., & Almuradova, D. M. (2021). A Modern Approach to Diagnostics, Prediction and Course of Renal Cell Cancer. Annals of the Romanian Society for Cell Biology, 25(1), 4429-4451.

Khakimova, G. G., Khakimov, G. A., Khakimova, S. G., Khakimov, A. T., & Almuradova, D. M. (2021). Changes In Tumor Infiltrating Lymphocytes Of Peripheral Blood And Tissue During Chemotherapy In Patients With Gastric Cancer. The American Journal of Medical Sciences and Pharmaceutical Research, 3(03), 20-31.

Almuradova, D. M. (2018). THE ROLE OF CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER. Journal of Drug Delivery & Therapeutics, 8(5), 163-167.

Atakhanova, N. E., Almuradova, D. M., Tursunova, N. I., & Ziyaev, S. V. (2023). Triple negative breast cancer and drug-resistant cells. World bulletin of public health (WBPH) in, 28.

Downloads

Published

2025-07-01